Hap Trading, LLC Crispr Therapeutics Ag Transaction History

Hap Trading, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$53.19 - $79.24 $219,674 - $327,261	-4,130 Reduced 27.39%	10,951 $687,000
Q4 2021 Feb 14, 2022	BUY	$70.09 - $111.29 $175,084 - $278,002	2,498 Added 19.85%	15,081 $1.14 Million
Q1 2021 May 14, 2021	BUY	$110.72 - $210.04 $224,650 - $426,171	2,029 Added 19.22%	12,583 $1.53 Million
Q4 2020 Feb 16, 2021	SELL	$79.67 - $173.23 $128,029 - $278,380	-1,607 Reduced 13.21%	10,554 $1.62 Million
Q2 2020 Aug 10, 2020	BUY	$38.5 - $76.05 $468,198 - $924,844	12,161 New	12,161 $894,000

491

58M

1.1M

1.9M

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.74B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.